Shares of Jubilant Life Sciences may remain active, as the company has received final approval for the generic version of Crestor tablets from the US Food and Drug Administration.
It has received ANDA approval for Rosuvastatin calcium tablets (5 mg, 10 mg, 20 mg, and 40 mg strengths), used for the treatment of disorders resulting from high lipid levels in blood. So far in 2016, it has received seven approvals from the USFDA.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.